Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2000-07-07
2002-10-08
Scheiner, Laurie (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120, C435S007210, C435S069300, C435S320100, C536S023100, C536S023720, C536S024300, C536S024310
Reexamination Certificate
active
06461811
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to newly identified polynucleotides, polypeptides, and fragments thereof encoded by porcine gamma-herpesvirus sequences, and methods of using the porcine gamma-herpesvirus nucleic acids and polypeptides.
BACKGROUND OF THE INVENTION
Organ procurement currently poses one of the major problems in solid organ transplantation, since the number of patients requiring transplants far exceeds the number of organs available. One means of eliminating the shortage of donor organs for allotransplantation is to develop the technologies required to transplant non-human organs into humans, i.e., xenotransplantation. The development of clinical xenotransplantation will also allow for the transplantation of non-human cells and tissues.
A potential problem lies in the fact that human and animal organs may be of very different size, depending on the species serving as donor, and on the possibility of infection due to microorganisms present in the donor tissues and having an ability to infect humans. Consequently, one strain of the domesticated pig, denoted miniature swine (
Sus scrofa
), appears suitable for such transplants because of its similar size to humans (see below). Furthermore, any use of pigs as organ donors in xenotransplantation would obviate problems associated with the consideration of non-human primates as donors. Xenografts from non-human primates, for example, present considerable risk of transmission of pathogens and the consequent development of emerging infections. In addition, several pathogens that cause disease are known to infect both humans and non-human primates, for example, in the transmission of HIV from the chimpanzee to humans. Furthermore, chimpanzees and orangutans, the closest non-human primates phylogenetically, are endangered species and far too rare to be considered for organ transplantation purposes. Baboons are too small to be an appropriate donor for most organ transplants. Even the largest baboons weigh less than 40 kg. In addition, the gestation times and productivity of primates would not allow a commercially significant generation of source animals.
The physiology of many organ systems of pigs has been shown to be highly similar to the human counterparts (Sachs, D. H. (1994)
Veterinary Immunology
&
Immunopathology
43:185-191). Thus, the miniature swine offers numerous advantages as potential xenograft donors. They achieve adult weights of approximately 100-150 kg, a size that is more compatible to human weights than that of the domestic pig, which reaches weights of over 500 kg. Through a selective breeding program over the past 20 years, partially inbred, miniature swine have been produced (Sachs et al. (1976)
Transplantation
22: 559-567; Sachs, D. H. (1992) In
Swine as models in biomedical research
, eds M. Swindle, D. Moody, and L. Phillips, pp. 3-15. Ames Iowa State Univ. Press; Sachs, (1994)
Veterinary Immunology
&
Immunopathology
43: 185-191). This breeding program has resulted in herds of animals that are genetically well characterized and inbred at the major histocompatibility complex (MHC). These animals have been used in large animal model studies for many years and have, like their domestic counterparts, very favorable breeding characteristics for being used as donors of organs in xenotransplantation.
A central concern regarding xenotransplantation is the risk of xenosis, infection by organisms transferred with the xenograft into both the transplant recipient and the general population. In particular, “emerging infections” caused by new and previously unknown infectious agents with altered pathogenicity, have to be considered as a potential risk associated with xenotransplantation. The risk of viral infection is increased in transplantation by the presence of factors commonly associated with viral activation, e.g., immune suppression, graft-versus-host disease, graft rejection, viral co-infection, and cytotoxic therapies.
Herpesviruses are the causative agents of many diseases that share a commonality of latency and recurrent infections. Herpesviruses may persist for years in a dormant state and become reactivated after later provocation. While the herpesviruses are widely separated in terms of genomic sequence and proteins, many are similar in terms of virion structure and genome organization. Herpesvirus represents a DNA virus family containing a central icosahedral core of double-stranded DNA. There is a lipoprotein envelope that is trilaminar and 100-200 nm in diameter and a nucleus that is 30-43 nm in diameter. The genome size is large, up to 235 kbp DNA. Based upon the structural and morphological features, the herpesvirus family is divided into three main families: alpha, beta, and gamma. Examples of alpha herpesviruses are herpes simplex and varicella zoster, examples of beta herpesviruses are cytomegalovirus and human herpesvirus 6 while examples of gamma-herpesviruses are Epstein Barr virus and human herpesvirus 8.
Prior to this invention, members of three porcine herpesvirus families had been identified, namely of the alpha, beta, and gamma-herpesvirus families. Suid herpesvirus 1 (SHV1), which causes pseudorabies (PRV) in pigs, is an alpha-herpesvirus and results in neonatal death of piglets, and can be eradicated by vaccination. The glycoprotein II gene of SHV1 is reportedly closely related to the gpB gene of other herpesviruses (Robbins et al. (1987)
J. Virology.
61:2691-2701). Suid herpesvirus 2 (SHV2), also known as pig cytomegalovirus (pCMV), is found in the respiratory tract of pigs and causes atopic rhinitis, abortion, or neonatal piglet losses. Only the DNA polymerase gene of SHV2 has been reported (Genbank Accession Number AJ222640). Detection of two novel porcine herpesviruses with high similarity to other gamma-herpesviruses were recently reported (Ehlers et al. (1999)
J. General Virology,
80:971-978), wherein the sequence of the DNA polymerase gene was reported (Genbank Accession Numbers AF118399 and AF118401).
Subsequent examination, as disclosed herein, of pigs for the presence of a gamma-herpesvirus by PCR methods designed to amplify the DNA regions encoding all or part of the glycoprotein B (gpB) envelope molecule has resulted in the detection of sequence similarity to other known gamma-herpesviruses.
BRIEF SUMMARY OF THE INVENTION
It is an object of the present invention to provide isolated polynucleotide sequences encoding a polypeptide that corresponds to a novel porcine gamma-herpesvirus glycoprotein B, herein called pGHV-gpB. Such sequences may be derived from genomic DNA.
It is another object of the present invention to provide immunogenically active fragments and segments of said polynucleotide for use as probes in the detection of similar sequences in related organisms.
A further object of this invention is to use the polypeptides and fragments thereof of the invention to provide a vaccine against porcine gamma-herpesvirus organisms, which vaccine is useful to protect a pig from productive proliferation of this, or related, gamma-herpesvirus organisms.
A still further object of the present invention is to provide antibodies that are capable of binding to an epitope on the porcine gamma-herpesvirus gpB polypeptides, and fragments, of the invention. Such antibodies are useful for diagnosis of the presence of pGHV-gpB polypeptides or as part of a vaccination program.
REFERENCES:
Pharmacia BioDirectory catalog. 1996. p. 225.*
Simas, et al., “Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis,” Trends in Microbiology, vol. 6, No. 7, pp. 276-282 (Ju. 1998).
Bahr, et al., “Structural organization of a conserved gene cluster of Tupaia herpesvirus encoding the DNA polymerase, glycoprotein B, a probable processing and transport protein, and the major DNA binding protein,” Virus Research, pp. 123-136 (1999).
Ehlers, et al., “Detection of two novel porcine herpesviruses with high similarity to gammaherpesviruses,” Journal of General Virology, pp. 971-978 (1999).
Ulrich, et al., “Characterization of the DNA polymerase
BioTransplant, Inc.
Foley Shanon A.
Grant Alan J.
Olstein Elliot M.
Scheiner Laurie
LandOfFree
Gamma-herpes virus DNA and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-herpes virus DNA and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-herpes virus DNA and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2982227